Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment

Gladys Maribel Hidalgo-Lozada,Angelica Villarruel-López,Karla Nuño,Abel García-García,Yaír Adonaí Sánchez-Nuño,César Octavio Ramos-García
DOI: https://doi.org/10.3390/ijms25052671
IF: 5.6
2024-02-26
International Journal of Molecular Sciences
Abstract:The prevalence and incidence of obesity and the comorbidities linked to it are increasing worldwide. Current therapies for obesity and associated pathologies have proven to cause a broad number of adverse effects, and often, they are overpriced or not affordable for all patients. Among the alternatives currently available, natural bioactive compounds stand out. These are frequently contained in pharmaceutical presentations, nutraceutical products, supplements, or functional foods. The clinical evidence for these molecules is increasingly solid, among which epigallocatechin-3-gallate, ellagic acid, resveratrol, berberine, anthocyanins, probiotics, carotenoids, curcumin, silymarin, hydroxy citric acid, and α-lipoic acid stand out. The molecular mechanisms and signaling pathways of these molecules have been shown to interact with the endocrine, nervous, and gastroenteric systems. They can regulate the expression of multiple genes and proteins involved in starvation–satiety processes, activate the brown adipose tissue, decrease lipogenesis and inflammation, increase lipolysis, and improve insulin sensitivity. This review provides a comprehensive view of nature-based therapeutic options to address the increasing prevalence of obesity. It offers a valuable perspective for future research and subsequent clinical practice, addressing everything from the molecular, genetic, and physiological bases to the clinical study of bioactive compounds.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the treatment and prevention of obesity and its related complications. Although current treatment methods for obesity and its related pathologies exist, they are often accompanied by a wide range of adverse reactions and are expensive or unaffordable for some patients. Therefore, this review paper focuses on the clinical application of effective molecules from natural sources in the prevention and treatment of obesity. These molecules are usually found in pharmaceutical preparations, nutritional supplements, and functional foods. They regulate the hunger - satiety process, activate brown adipose tissue, reduce lipid synthesis and inflammation, increase lipolysis, and improve insulin sensitivity through interactions with the endocrine, nervous, and gastrointestinal systems. Specifically, the paper discusses the clinical evidence and mechanism of action of molecules such as epigallocatechin gallate (EGCG), ellagic acid, resveratrol, berberine, anthocyanins, probiotics, carotenoids, curcumin, silymarin, hydroxycitric acid, and alpha - lipoic acid. By analyzing the results of clinical trials of these natural molecules, the paper aims to provide valuable perspectives for future research and clinical practice, covering multiple aspects from molecular and genetic to physiological bases and then to clinical studies of bioactive compounds. This will not only help develop safer and more effective obesity treatment strategies but may also provide new ideas for individualized treatment plans for obese patients.